Embla Medical hf (FRA:5IQ) Cyclically Adjusted FCF per Share: €0.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5IQ Embla Medical hf FRA:5IQ
71 GF Score
Price €3.51
GF Value €4.51
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf Cyclically Adjusted FCF per Share?

Embla Medical hf FRA:5IQ -2.64% 71 Cyclically Adjusted FCF per Share is €0.16 as of Mar. 2026. GuruFocus rates FRA:5IQ with a GF Score™ of 71/100 and a GF Value™ of €4.51 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Embla Medical hf's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.008. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Embla Medical hf was 10.40% per year. The lowest was 5.50% per year. And the median was 7.90% per year.

As of today (2026-07-20), Embla Medical hf's current stock price is €3.505. Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.16. Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is 21.91.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 21.76. And the median was 41.47.


Embla Medical hf  (FRA:5IQ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=3.505/0.16
=21.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 21.76. And the median was 41.47.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Embla Medical hf Cyclically Adjusted FCF per Share Related Terms


Embla Medical hf Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Cyclically Adjusted FCF per Share Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.16

Embla Medical hf Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.15 0.16 0.16

FRA:5IQ vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted Price-to-FCF falls into.


FRA:5IQ
71GF Score
Embla Medical hf FRA:5IQ
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.008/158.5100*158.5100
=0.008

Current CPI (Mar. 2026) = 158.5100.

Embla Medical hf Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.007 101.923 0.011
201609 0.033 102.457 0.051
201612 0.036 102.562 0.056
201703 0.005 102.768 0.008
201706 0.028 103.496 0.043
201709 0.028 103.871 0.043
201712 0.048 104.481 0.073
201803 -0.009 105.600 -0.014
201806 0.019 106.206 0.028
201809 0.036 106.727 0.053
201812 0.031 108.388 0.045
201903 0.008 108.702 0.012
201906 0.037 109.758 0.053
201909 0.078 109.922 0.112
201912 0.014 110.588 0.020
202003 0.036 111.019 0.051
202006 0.041 112.667 0.058
202009 0.045 113.772 0.063
202012 0.021 114.542 0.029
202103 0.019 115.833 0.026
202106 0.043 117.451 0.058
202109 0.026 118.723 0.035
202112 0.059 120.398 0.078
202203 0.010 123.555 0.013
202206 0.003 127.809 0.004
202209 0.028 129.810 0.034
202212 0.035 131.901 0.042
202303 -0.005 135.674 -0.006
202306 0.023 139.150 0.026
202309 0.039 140.147 0.044
202312 0.058 142.125 0.065
202403 -0.016 144.910 -0.018
202406 0.039 147.267 0.042
202409 0.069 147.722 0.074
202412 0.078 148.871 0.083
202503 0.016 150.393 0.017
202506 0.025 153.367 0.026
202509 0.076 153.800 0.078
202512 0.086 155.560 0.088
202603 0.008 158.510 0.008

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.16 mean?
Embla Medical hf (FRA:5IQ) has a Cyclically Adjusted FCF per Share of €0.16 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Cyclically Adjusted FCF per Share too high?
Embla Medical hf's current Cyclically Adjusted FCF per Share is €0.16. Overall, Embla Medical hf has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Embla Medical hf's Cyclically Adjusted FCF per Share of €0.16 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Cyclically Adjusted FCF per Share is €0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (FRA:5IQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.51, compared to a current price of €3.51 — trading 22.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.16. Embla Medical hf's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Embla Medical hf (FRA:5IQ), the current Cyclically Adjusted FCF per Share is €0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (FRA:5IQ) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of €3.51 is trading 22.3% below its estimated GF Value™ of €4.51. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for FRA:5IQ:

  • Cyclically Adjusted FCF per Share: €0.16
  • GF Value™: €4.51 vs. price of €3.51 (22.3% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the FRA:5IQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Other Exchanges 0FIW:UKEMBLA:Denmark
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
71GF Score

Get the complete analysis for FRA:5IQ

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.51
Price
€4.51
GF Value